Ravina Bernard 4
4 · Voyager Therapeutics, Inc. · Filed Sep 13, 2017
Insider Transaction Report
Form 4
Ravina Bernard
Chief Medical Officer
Transactions
- Sale
Common Stock
2017-07-20$10.00/sh−5,490$54,900→ 49,413 total - Sale
Common Stock
2017-09-11$14.30/sh−10,980$157,014→ 32,943 total
Footnotes (5)
- [F1]The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]This total reflects the number of shares beneficially owned by the reporting person on July 20, 2017, following the reported transaction.
- [F3]This total reflects an adjustment for a clerical error on the reporting person's Form 3 wherein the number of shares beneficially owned was inadvertently overstated by 62,744 shares. Such shares were sold prior to Dr. Ravina becoming a reporting person.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to $14.95, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., any security holder of Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (4) to this Form 4.
- [F5]This total reflects the number of shares beneficially owned by the reporting person as of the date hereof, following the reported transaction and inclusive of all intervening transactions.